Bipolar Forceps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Bipolar Forceps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The bipolar forceps market is expected to register a CAGR of 5.2% over the forecast period.

COVID-19 had a substantial impact on the bipolar forceps market due to its unexpected spread. For instance, as per the article published in 2020 under the title ‘Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 1’, the effect of COVID-19 on a surgeon's routine practice and surgical education has been significant. Surgery has evolved into a crucial staff resource for the healthcare systems dealing with the COVID-19 epidemic because of the cancellation of elective and non-urgent surgeries. During COVID-19, surgeons implemented non-surgical alternatives to treat their patients. In such scenarios, the utilization of surgical instruments such as bipolar forceps, scalpels, and scissors was limited or less. Furthermore, as per the article published in 2020 under the heading ‘Impact of Personal Protective Equipment on Surgical Performance During the COVID-19 Pandemic’, while utilizing personal protective equipment (PPE) during emergency surgery on COVID-19 patients, surgeons felt that sight, communication, and other non-technical skills were hindered. Their perceived lack of safety and comfort as well as growing exhaustion was likely to be prevented them from doing surgery at their best. Hence as per the factors mentioned above, COVID-19 had a significant impact on the bipolar forceps market.

The major drivers propelling the growth of the bipolar forceps market are the increasing prevalence of chronic diseases and the increasing adoption of minimally invasive procedures globally. According to the CDC 2020 report, 90% of the nation’s USD 3.8 trillion per year healthcare costs were likely to be attributed to people with chronic diseases and mental health conditions. Furthermore, as per the report from Commentary on Chronic Disease Prevention in 2022, a recent ‘Partnership to Fight Chronic Disease’ publication showed that treatment of the seven most common chronic diseases, coupled with productivity losses, was anticipated to cost the U.S. economy USD 2 trillion dollars annually which is likely to be USD 8,600 per person by 2030. Additionally, the increasing investments in the research and development activities for the innovation of advanced bipolar forceps products by major players are expected to drive the market. Thus, considering the mentioned facts and key drivers, the studied market is anticipated to propel over the forecast period.

As a result of the reasons outlined, the explored market is anticipated to grow throughout the analysis period. However, the lack of awareness regarding advanced surgical devices and the high cost of devices in developing countries restrain the market growth.

Key Market TrendsThe Disposable Segment is Expected to Grow Significantly Over the Forecast Period

The disposable bipolar forceps are sterile single-use instruments mostly available in stainless steel. The disposable bipolar forceps offer freedom from autoclaving and reprocessing, repair, and repeated handling, and are cost-effective instruments. Some of the disposable bipolar forceps available commercially include LIBERTY, COHEN, LIBERTY AURA, ActiLine EcoCeps, and many more. Among the disposable bipolar forceps, non-stick bipolar forceps are highly used as it provides various benefits such as prevention of tissue sticking to the tip, don’t require cleaning, reduce toxic surgical smoke, and are compatible with standard electrosurgery units. The Stryker Corporation's Spetzler-Malis Disposable Bipolar Forceps is one such non-stick bipolar forceps that delivers optimal sightlines, balanced high-comfort ergonomics, and superb non-stick coagulation performance. Thus, in view of the increased advantages of disposable bipolar forceps, the studied segment is expected to grow over the forecast period.

Furthermore, the presence of competitors, product launches, and improved annual revenue in the disposable bipolar forceps segment competitors boost the market growth. For instance, Integra LifeSciences’s annual revenue for the segment Codman Specialty Surgical was registered as more than 1 million (1,025,232) in the financial year 2021. The segment has revenue from its product range named ‘CODMAN VersaTru’, a standard disposable non-stick bipolar forceps having active heat transfer (AHT) technology that controls tip and tissue temperature. Furthermore, regulatory approvals and product launches relating to the disposable bipolar forceps fuel market growth. For instance, In February 2022, Erbe Elektromedizin GmbH launched 12 new single-use bipolar forceps that are likely to be available in the CE and CE-related markets.

As a result of the aforementioned factors, the disposable bipolar forceps segment is predicted to develop significantly throughout the forecast period.

North America Dominates the Market and is Expected to Grow During the Forecast Period

Factors such as the adoption of minimally invasive procedures and the increasing prevalence of chronic diseases are expected to drive the growth of the studied market in North America. According to the 2022 update from CDC, six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of health care costs up to USD 4.1 Trillion annually. Additionally, most of the major players in the studied market such as Johnson and Johnson, Medtronic, CONMED Corporation, Becton, Dickinson, and Company, and many more are concentrated in the United States. Thus, in view of the aforementioned factors, North America is expected to propel significantly in the Bipolar Forceps market over the forecast period.

Moreover, the increasing number of research and development in the field of bipolar forceps in the studied region boosts the market growth. For instance, as per the article published in 2022 under the title ‘Comparison of operative outcomes between monopolar and bipolar coagulation in hepatectomy: a propensity score-matched analysis in a single center’, To lessen intraoperative bleeding, a saline-coupled bipolar forceps coagulation system is regarded as a trustworthy and safe hemostatic tool. When compared to the use of bipolar forceps devices, the use of monopolar forceps devices was anticipated to raise the occurrence of problems including intra-abdominal infection and ascites. Hence it is advisable to use bipolar forceps and which leads to the adoption of bipolar forceps at a higher pace and boosts the market growth.

The analyzed market is predicted to grow in the North American region because of the preceding factors.

Competitive Landscape

The Bipolar Forceps market is highly competitive and consists of many major players, that dominate the market. The major players of the studied market include Stryker Corporation, CONMED Corporation, Medtronic plc,B. Braun Melsungen AG, Johnson and Johnson,KLS Martin Group, Becton, Dickinson and Company and many more. The major players are evolving various strategies such as investment in Research and Development, collaborations and acquisitions for the expansion of their product portfolio.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.